Bioceres Crop Solutions Corp. (FRA:0G4)
Germany · Delayed Price · Currency is EUR 0.9600
-0.0500 (-4.95%)
Last updated: Jan 26, 2026, 9:55 AM CET
Bioceres Crop Solutions Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 318.16 | 333.34 | 464.83 | 419.45 | 328.46 | 206.7 | |
Revenue Growth (YoY) | -27.90% | -28.29% | 10.82% | 27.70% | 58.91% | 19.93% |
Cost of Revenue | 192.73 | 205.99 | 283.24 | 241.46 | 203.56 | 118.34 |
Gross Profit | 125.43 | 127.36 | 181.59 | 177.99 | 124.9 | 88.35 |
Selling, General & Admin | 103.24 | 108.05 | 106.97 | 99.4 | 65.31 | 45.08 |
Research & Development | 16.03 | 14.66 | 16.84 | 14.89 | 6.86 | 5.51 |
Other Operating Expenses | 11.07 | 13.51 | 17 | 10.7 | 14 | 0.32 |
Operating Expenses | 130.34 | 136.22 | 140.82 | 125 | 86.17 | 50.92 |
Operating Income | -4.91 | -8.86 | 40.77 | 52.99 | 38.73 | 37.44 |
Interest Expense | -28.12 | -25.63 | -24.12 | -21.23 | -14.95 | -18.92 |
Earnings From Equity Investments | -0.24 | -1.13 | 4.05 | 1.2 | 1.14 | 1 |
Currency Exchange Gain (Loss) | -5.48 | -7.05 | 3.42 | -9.52 | -12.49 | -13.38 |
Other Non Operating Income (Expenses) | -24.47 | -22.65 | -14.08 | -4.33 | 1.64 | 4.45 |
EBT Excluding Unusual Items | -63.22 | -65.32 | 10.04 | 19.11 | 14.06 | 10.58 |
Gain (Loss) on Sale of Assets | 7.75 | 7.75 | - | - | - | - |
Asset Writedown | - | - | - | - | - | -0.05 |
Other Unusual Items | - | - | 1.03 | - | - | - |
Pretax Income | -55.47 | -57.57 | 11.07 | 19.11 | 14.06 | 10.53 |
Income Tax Expense | 4.62 | 1.27 | 3.78 | -1.07 | 17.97 | 14.35 |
Earnings From Continuing Operations | -60.1 | -58.85 | 7.29 | 20.17 | -3.91 | -3.82 |
Minority Interest in Earnings | 3.72 | 3.43 | -3.01 | -1.39 | -3.29 | -3.05 |
Net Income | -56.37 | -55.42 | 4.28 | 18.78 | -7.2 | -6.87 |
Net Income to Common | -56.37 | -55.42 | 4.28 | 18.78 | -7.2 | -6.87 |
Net Income Growth | - | - | -77.23% | - | - | - |
Shares Outstanding (Basic) | 63 | 63 | 63 | 62 | 42 | 39 |
Shares Outstanding (Diluted) | 63 | 63 | 63 | 63 | 42 | 39 |
Shares Change (YoY) | -0.18% | -0.40% | 0.47% | 49.37% | 7.86% | 7.69% |
EPS (Basic) | -0.89 | -0.88 | 0.07 | 0.30 | -0.17 | -0.18 |
EPS (Diluted) | -0.89 | -0.88 | 0.07 | 0.30 | -0.17 | -0.18 |
EPS Growth | - | - | -77.35% | - | - | - |
Free Cash Flow | 54.09 | 44.26 | 31.93 | -8.77 | -20.97 | -9.01 |
Free Cash Flow Per Share | 0.85 | 0.70 | 0.50 | -0.14 | -0.50 | -0.23 |
Gross Margin | 39.42% | 38.21% | 39.07% | 42.43% | 38.03% | 42.74% |
Operating Margin | -1.54% | -2.66% | 8.77% | 12.63% | 11.79% | 18.11% |
Profit Margin | -17.72% | -16.62% | 0.92% | 4.48% | -2.19% | -3.32% |
Free Cash Flow Margin | 17.00% | 13.28% | 6.87% | -2.09% | -6.39% | -4.36% |
EBITDA | 11.81 | 7.61 | 57.98 | 68.81 | 46.66 | 42.48 |
EBITDA Margin | 3.71% | 2.28% | 12.47% | 16.41% | 14.21% | 20.55% |
D&A For EBITDA | 16.71 | 16.47 | 17.21 | 15.82 | 7.93 | 5.04 |
EBIT | -4.91 | -8.86 | 40.77 | 52.99 | 38.73 | 37.44 |
EBIT Margin | -1.54% | -2.66% | 8.77% | 12.63% | 11.79% | 18.11% |
Effective Tax Rate | - | - | 34.14% | - | 127.79% | 136.28% |
Revenue as Reported | - | - | - | - | - | 209.53 |
Advertising Expenses | - | 4.51 | 5.01 | 5.67 | 4.84 | 2.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.